5 analysts have shared their evaluations of Stem (NYSE:STEM) during the recent three months, expressing a mix of bullish and bearish perspectives.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $4.05, a high estimate of $6.00, and a low estimate of $3.00. This current average represents a 26.36% decrease from the previous average price target of $5.50.

Investigating Analyst Ratings: An Elaborate Study

The analysis of recent analyst actions sheds light on the perception of Stem by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Stem's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.

Stay up to date on Stem analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Discovering Stem: A Closer Look

Breaking Down Stem's Financial Performance

Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.

Positive Revenue Trend: Examining Stem's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 34.41% as of 30 September, 2023, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.

Net Margin: Stem's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -57.63% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): Stem's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -15.86%, the company may encounter challenges in delivering satisfactory returns for shareholders.

Return on Assets (ROA): Stem's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -5.31%, the company may encounter challenges in delivering satisfactory returns from its assets.

Debt Management: Stem's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.18, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.

Understanding the Relevance of Analyst Ratings

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.